Ramsay Healthcare and St John of God Health Care have emerged as potential players in the race to save Healthscope.
Europe’s market for initial public offerings has gotten off to an uneven start this year, but advisers say the deals offer ...
British drugmaker Indivior on Thursday projected a 17% decline in 2025 net revenue at the midpoint of its forecast range, partly hurt by sluggish sales of its film-form medication-assisted therapy for ...
TOKYO (Reuters) - U.S. private equity firm KKR has secured a 57.92% stake in Fuji Soft after the second stage of its tender ...
KKR & Co. has secured enough shares of Fuji Soft Inc. in a tender offer to take the company private, according to people ...
German medical packaging maker Gerresheimer has garnered interest from US medical solutions company Phillips-Medisize and buyout firm Bain Capital for parts or all of Gerresheimer, Bloomberg News ...
When Cornerstone Home Lending acquired Roscoe Bank in 2022, they didn’t just become the first mortgage lender in Texas to ...
The roughly 170 child care centers in Colorado owned or backed by private equity firms include big names such as KinderCare, ...
While the interfund transfer was not yet signed off, it was on track to complete in coming weeks, limited partner sources ...
ITC’s consumer businesses are struggling. Moreover, it has its own frozen meats and seafood brand, ITC Master Chef. It also ...
Kirkland & Ellis advised Bain Capital on the takeover of a leading European real estate and facility management group from ...
Olema Pharmaceuticals is developing palazestrant, an oral SERD in phase 3 trials for ER+/HER2- metastatic breast cancer. Read why OLMA stock is a Hold.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results